Arbutus Pharma Corp. and others sue Pfizer Inc. in District of New Jersey
Case Summary
Arbutus Pharma Corp. and others sued Pfizer Inc. and others in the District of New Jersey case 23-cv-01876. The complaint's allegations are not detailed, leaving the legal issues and potential damages unclear.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Key Issues
- • Pharmaceutical litigation
- • Complaint filed
- • Unspecified claims
Docket Snapshot
Court
D.N.J.
District of New Jersey · 3rd Circuit · NJ
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
3:23-cv-01876 ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
Other · Apr 23, 2026
Coverage
1 article
1 source tracked
Participants
1 Plaintiff
2 linked entities
Judge
Not assigned in feed
What the record shows
This case is tied to District of New Jersey, a federal district court in NJ.
The newest docket activity we have is a other dated April 23, 2026.
The visible party/entity graph currently includes 3:23-cv-01876 ARBUTUS PHARMA CORP and others.
Press monitoring has found 1 related article from 1 distinct source.
The Story So Far
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al is an active civil matter in District of New Jersey under docket 23-cv-01876.
The main identified plaintiff or petitioner is 3:23-cv-01876 ARBUTUS PHARMA CORP. The case is currently organized around Current docket activity and next procedural step, Patent validity, infringement, and damages, Federal jurisdiction and procedural posture, Intellectual-property ownership and infringement.
The available docket gives enough signal to track the case, but not enough to overstate the merits. This page will become more useful as filings, orders, hearings, and party appearances add detail.
On April 23, 2026, the docket recorded a other: The court denied a motion in the case of Arbutus Pharma Corp. et al, which is a significant development in the ongoing patent dispute between the two pharmaceutical companies. The motion was likely aimed at delaying or blocking the case's.
The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.
About This Court
District of New Jersey (D.N.J.) is a federal district court in the 3rd Circuit, NJ.
Case Timeline
1 event3:23-cv-01876 ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
The court denied a motion in the case of Arbutus Pharma Corp. et al v. Pfizer Inc. et al, which is a significant development in the ongoing patent dispute between the two pharmaceutical companies. The motion was likely aimed at delaying or blocking the case's progress, but the court's denial means the case will continue. This decision has important implications for the companies involved and the broader pharmaceutical industry.
Press Coverage
settings_backup_restore Data provenance expand_more
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
18 hours, 19 minutes ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.